IOVA — Iovance Biotherapeutics Share News
0.000.00%
Last trade - 00:00- $6.67bn
- $6.37bn
- $263.50m
FDA approves Iovance Biotherapeutics cell therapy for skin cancer
U.S. STOCKS ON THE MOVE-First Solar, Fusion Pharmaceuticals, MicroStrategy
U.S. STOCKS ON THE MOVE-Tesla, Gold miners, Weyerhaeuser
U.S. RESEARCH ROUNDUP-Expedia Group, Meta Platforms, Rayzebio
U.S. STOCKS ON THE MOVE-Reneo Pharma, Cytokinetics, Burford Capital
Iovance falls after U.S. FDA puts hold on lung cancer therapy trial
US FDA places clinical hold on Iovance's lung cancer treatment trial (updated)
Brief: Iovance Biotherapeutics Announces Clinical Program Update For Ln-145 In Non-Small Cell Lung Cancer
US FDA places clinical hold on Iovance's lung cancer treatment trial
Iovance Biotherapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Paramount Global, Canopy Growth, Moderna
U.S. STOCKS ON THE MOVE-PTC Therapeutics, Gold miners, Copper miners
Iovance rises as investors brush off regulatory delay for cancer drug
Brief: U.S. Food And Drug Administration Updates Prescription Drug User Fee Act Action Date For Lifileucel For The Treatment Of Advanced Melanoma
Iovance Biotherapeutics Inc reports results for the quarter ended in June - Earnings Summary
Iovance Biotherapeutics Inc expected to post a loss of 80 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Zillow Group, TransAlta, Everbridge
U.S. STOCKS ON THE MOVE-EBay, Newell Brands, Semler Scientific
U.S. STOCKS ON THE MOVE-VeriSign, Equitrans Midstream, Nutrien